Dr. Shane Stecklein, MD, PhD
Claim this profileUniversity of Kansas Cancer Center
Studies Breast Cancer
Studies Uterine Tumors
6 reported clinical trials
16 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
Stage IV
Stage II
2Uterine Tumors
Stage IV
HER2 negative
ER negative
Affiliated Hospitals
Clinical Trials Shane Stecklein, MD, PhD is currently running
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
More about Shane Stecklein, MD, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Shane Stecklein, MD, PhD has experience with
- Radiation
- Carboplatin
- Cyclophosphamide
- Docetaxel
- Doxorubicin
- Pembrolizumab
Breakdown of trials Shane Stecklein, MD, PhD has run
Breast Cancer
Bone Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shane Stecklein, MD, PhD specialize in?
Shane Stecklein, MD, PhD focuses on Breast Cancer and Uterine Tumors. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage IV.
Is Shane Stecklein, MD, PhD currently recruiting for clinical trials?
Yes, Shane Stecklein, MD, PhD is currently recruiting for 4 clinical trials in Kansas City Kansas. If you're interested in participating, you should apply.
Are there any treatments that Shane Stecklein, MD, PhD has studied deeply?
Yes, Shane Stecklein, MD, PhD has studied treatments such as Radiation, Carboplatin, Cyclophosphamide.
What is the best way to schedule an appointment with Shane Stecklein, MD, PhD?
Apply for one of the trials that Shane Stecklein, MD, PhD is conducting.
What is the office address of Shane Stecklein, MD, PhD?
The office of Shane Stecklein, MD, PhD is located at: University of Kansas Cancer Center, Kansas City, Kansas 66160 United States. This is the address for their practice at the University of Kansas Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.